| • | The Valproate in Partial Epilepsy (VIPE) study was aimed to assess the utility of candesartan in the regression of left ventricular hypertrophy in clinical practice. | ||||
The correct reference annotation is given below:
| • | The VIPE study was aimed to assess the utility of candesartan in the regression of left ventricular hypertrophy in clinical practice. | ||||
The editors of Expert Review of Cardiovascular Therapy would like to sincerely apologize for any inconvenience or confusion this may cause our readers.